000 01562 a2200433 4500
005 20250517091102.0
264 0 _c20180702
008 201807s 0 0 eng d
022 _a1552-4957
024 7 _a10.1002/cyto.b.21374
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJohansson, Pegah
245 0 0 _aValidation of a flow cytometry-based detection of γ-H2AX, to measure DNA damage for clinical applications.
_h[electronic resource]
260 _bCytometry. Part B, Clinical cytometry
_c11 2017
300 _a534-540 p.
_bdigital
500 _aPublication Type: Journal Article; Validation Study
650 0 4 _aAminoglycosides
_xpharmacology
650 0 4 _aAtaxia Telangiectasia
_xgenetics
650 0 4 _aChromones
_xpharmacology
650 0 4 _aDNA
_xdrug effects
650 0 4 _aDNA Breaks, Double-Stranded
_xdrug effects
650 0 4 _aDNA Repair
_xdrug effects
650 0 4 _aDose-Response Relationship, Radiation
650 0 4 _aEnediynes
_xpharmacology
650 0 4 _aFlow Cytometry
_xmethods
650 0 4 _aGamma Rays
650 0 4 _aHistones
_xgenetics
650 0 4 _aHumans
650 0 4 _aLeukocytes, Mononuclear
_xdrug effects
650 0 4 _aMorpholines
_xpharmacology
650 0 4 _aPhosphorylation
650 0 4 _aPrimary Cell Culture
650 0 4 _aPyrones
_xpharmacology
700 1 _aFasth, Anders
700 1 _aEk, Torben
700 1 _aHammarsten, Ola
773 0 _tCytometry. Part B, Clinical cytometry
_gvol. 92
_gno. 6
_gp. 534-540
856 4 0 _uhttps://doi.org/10.1002/cyto.b.21374
_zAvailable from publisher's website
999 _c25908322
_d25908322